These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26996987)

  • 1. Detoxification from opiate drugs during pregnancy.
    Bell J; Towers CV; Hennessy MD; Heitzman C; Smith B; Chattin K
    Am J Obstet Gynecol; 2016 Sep; 215(3):374.e1-6. PubMed ID: 26996987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program.
    Olsen M
    South Med J; 2020 Nov; 113(11):553-558. PubMed ID: 33140108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids affect the fetal brain: reframing the detoxification debate.
    Caritis SN; Panigrahy A
    Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal Outcomes with Detoxification from Opioid Drugs during Pregnancy: A Systematic Review.
    Towers CV; Terry P; Rackley B; Hennessy M; Visconti K
    Am J Perinatol; 2020 Jun; 37(7):679-688. PubMed ID: 31104311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
    ;
    Obstet Gynecol; 2012 May; 119(5):1070-6. PubMed ID: 22525931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
    Wolf ER; Tong ST; Sabo RT; Woolf SH; Abbinanti K; Pecsok J; Krist AH
    BMC Pediatr; 2019 Oct; 19(1):371. PubMed ID: 31640614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy.
    Stewart RD; Nelson DB; Adhikari EH; McIntire DD; Roberts SW; Dashe JS; Sheffield JS
    Am J Obstet Gynecol; 2013 Sep; 209(3):267.e1-5. PubMed ID: 23727040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.
    O'Connor A; Alto W; Musgrave K; Gibbons D; Llanto L; Holden S; Karnes J
    J Am Board Fam Med; 2011; 24(2):194-201. PubMed ID: 21383220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Management in Pregnancy and Postpartum.
    Brown HL
    Obstet Gynecol Clin North Am; 2020 Sep; 47(3):421-427. PubMed ID: 32762927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomous Care Pathway to Patient Opioid Abstinence: Should All Programs Offer this Approach?
    Patel A; Dietz P; Casto A; DePond J; Taylor L; Seybold D; Blake A; Calhoun B
    Issues Law Med; 2021; 36(2):193-210. PubMed ID: 36629776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.